Rabbit Anti-BCHE Recombinant Antibody (
1E9) (V2LY-0725-LY1117)

Xing, S., Li, Q., Xiong, B., Chen, Y., Feng, F., Liu, W., & Sun, H. (2021). Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer's disease, and fat metabolism. Medicinal Research Reviews, 41(2), 858-901.

Li, Q., Chen, Y., Xing, S., Liao, Q., Xiong, B., Wang, Y., ... & Sun, H. (2021). Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection. Journal of Medicinal Chemistry.

Pohanka, M., & Zakova, J. (2021). A Smartphone Camera Colorimetric Assay of Acetylcholinesterase and Butyrylcholinesterase Activity. Sensors, 21(5), 1796.

Jasiecki, J., & Wasąg, B. (2019). Butyrylcholinesterase protein ends in the pathogenesis of alzheimer’s disease—could BCHE genotyping Be helpful in Alzheimer’s therapy?. Biomolecules, 9(10), 592.

Zorbaz, T., Malinak, D., Kuca, K., Musilek, K., & Kovarik, Z. (2019). Butyrylcholinesterase inhibited by nerve agents is efficiently reactivated with chlorinated pyridinium oximes. Chemico-biological interactions, 307, 16-20.

Boyko, K. M., Baymukhametov, T. N., Chesnokov, Y. M., Hons, M., Lushchekina, S. V., Konarev, P. V., ... & Kovalchuk, M. V. (2019). 3D structure of the natural tetrameric form of human butyrylcholinesterase as revealed by cryoEM, SAXS and MD. Biochimie, 156, 196-205.

Lu, X., Yang, H., Li, Q., Chen, Y., Li, Q., Zhou, Y., ... & Sun, H. (2019). Expansion of the scaffold diversity for the development of highly selective butyrylcholinesterase (BChE) inhibitors: Discovery of new hits through the pharmacophore model generation, virtual screening and molecular dynamics simulation. Bioorganic chemistry, 85, 117-127.

Liu, S. Y., Xiong, H., Yang, J. Q., Yang, S. H., Li, Y., Yang, W. C., & Yang, G. F. (2018). Discovery of butyrylcholinesterase-activated near-infrared fluorogenic probe for live-cell and in vivo imaging. ACS sensors, 3(10), 2118-2128.

Dong, M. X., Xu, X. M., Hu, L., Liu, Y., Huang, Y. J., & Wei, Y. D. (2017). Serum butyrylcholinesterase activity: a biomarker for Parkinson’s disease and related dementia. BioMed research international, 2017.

Onder, S., David, E., Tacal, O., Schopfer, L. M., & Lockridge, O. (2017). Hupresin retains binding capacity for butyrylcholinesterase and acetylcholinesterase after sanitation with sodium hydroxide. Frontiers in pharmacology, 8, 713.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols